Takotsubo Syndrome in Coronavirus Disease 2019
暂无分享，去创建一个
H. Moch | R. Manka | M. Mancone | J. Ghadri | C. Templin | Z. Varga | F. D’Ascenzo | F. Infusino | E. Bossone | A. Gotschy | I. Wittstein | A. Moreo | G. Secco | P. Meyer | S. Winnik | M. Giammaria | V. Cammann | K. A. Szawan | L. Gaido | M. Károlyi | V. L. Cammann
[1] A. Levin,et al. Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial. , 2020, Journal of the American Society of Nephrology : JASN.
[2] B. Zinman,et al. Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial , 2020, Journal of the American Heart Association.
[3] Mohammad Madjid,et al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.
[4] Roberto Maroldi,et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.
[5] A. Tsapas,et al. The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. , 2019, Journal of hypertension.
[6] B. Zinman,et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. , 2019, The New England journal of medicine.
[7] R. Guthrie. Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.
[8] Isabelle Boutron,et al. A revised tool for assessing risk of bias in randomized trials , 2016 .
[9] K. Bybee,et al. Stress-Related Cardiomyopathy Syndromes , 2008, Circulation.
[10] C. Hamm,et al. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. , 2007, European heart journal.
[11] C. S. Hirsch,et al. Human stress cardiomyopathy. Myocardial lesions in victims of homicidal assaults without internal injuries. , 1980, Human pathology.